Aytu Biopharma (AYTU) EBIT Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) EBIT Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.78% |
| Sep 30, 2025 | 15.82% |
| Jun 30, 2025 | -2.82% |
| Mar 31, 2025 | 20.16% |
| Dec 31, 2024 | 19.35% |
| Sep 30, 2024 | 27.79% |
| Jun 30, 2024 | 13.07% |
| Mar 31, 2024 | 17.97% |
| Dec 31, 2023 | 21.90% |
| Sep 30, 2023 | 23.99% |
| Jun 30, 2023 | 15.37% |
| Mar 31, 2023 | -2.61% |
| Dec 31, 2022 | -11.45% |
| Sep 30, 2022 | 16.13% |
| Jun 30, 2022 | -27.13% |
| Mar 31, 2022 | -61.52% |
| Dec 31, 2021 | -21.88% |
| Sep 30, 2021 | -35.94% |
| Jun 30, 2021 | -12.60% |
| Dec 31, 2020 | -13.09% |